{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-012983","form_type":"8-K","ticker":"AMRN","cik":"0000897448","company_name":"AMARIN CORP PLCUK","filed_at":"2023-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.717005+00:00","generated_at":"2026-06-17T01:42:23.020927+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Amarin appoints Aaron Berg as Interim CEO and adds Oliver O'Connor to Board, effective April 17, 2023","bullets":["Aaron Berg, EVP President-U.S., named Interim CEO and President; board searching for permanent CEO.","Berg's annual base salary set at $700,000; target bonus remains 50% of base salary.","Oliver O'Connor appointed to Board and Nominating & Corporate Governance Committee.","O'Connor brings 30+ years in government, policy, and pharma; currently CEO of Irish Pharmaceutical Healthcare Association.","Board expands to 8 directors, all independent, including one Irish-domiciled member."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-012983","json":"https://secwatch.observer/filing/0000950170-23-012983.json","markdown":"https://secwatch.observer/filing/0000950170-23-012983.md","text":"https://secwatch.observer/filing/0000950170-23-012983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/0000950170-23-012983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/amrn-20230417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:42:23.020927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a35b8f25e1","claim":"Aaron Berg was appointed as Interim Chief Executive Officer and President at AMARIN CORP PLCUK.","evidence_excerpt":"On April 17, 2023, the Board of Directors (the “Board”) of Amarin Corporation plc (the “Company”) appointed Aaron Berg, current Executive Vice President, President-U.S. of the Company, as the Interim Chief Executive Officer and President of the Company and as the interim principal executive officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/0000950170-23-012983-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and President"}],"fact_type":"executive_change"},{"claim_id":"e5f229056e","claim":"Oliver O'Connor was appointed as Director at AMARIN CORP PLCUK.","evidence_excerpt":"On April 17, 2023, the Board appointed Oliver O’Connor, 61, to the Board to a term commencing on such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/0000950170-23-012983-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}